National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2014 (No. 1) (No. PB 58 of 2014)

Link to law: https://www.comlaw.gov.au/Details/F2014L01061

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 58 of 2014 
National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2014 (No.1)
National Health Act 1953
I, Kim Bessell, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated       22 July 2014
 
 
 
 
 
 
 
 
 
KIM BESSELL
Assistant Secretary
Pharmaceutical Access Branch
Principal Pharmacy Advisor                                                                     
Pharmaceutical Benefits Division
Department of Health
1          Name of Instrument
            (1)        This Instrument is the National Health (IVF/GIFT Program)
                        Special Arrangement Amendment Instrument 2014 (No.1).
            (2)        This Instrument may also be cited as PB 58 of 2014.
2          Commencement
This Instrument commences on 1 August 2014.
3          Amendment of PB 93 of 2011
(1)                    Schedule 1 amends the National Health (IVF/GIFT Program) Special Arrangement 2011 (PB 93 of 2011).
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule Amendments
 
[1]           Schedule 1, after the entry for ‘Progesterone’, in the form ‘Vaginal Gel (prolonged release) 90 mg in single dose pre-filled applicator’
insert:
Progesterone
Vaginal Tablet 100 mg
Vaginal
Endometrin
FP
D(100)
 
[2]           Schedule 3, Treatment Condition Item 1
substitute:
1
A patient who:
(i) Has an antral follicle count of 20 or less; and
 (ii) Is undergoing a gonadotrophin releasing hormone antagonist cycle
Corifollitropin Alfa
Solution for injection 100 micrograms in 0.5 mL single dose pre-filled syringes
 
[3]           Schedule 3, after Treatment Conditions, Item 2
Insert:
3
The treatment must be for luteal phase support
 
Progesterone
Vaginal gel (prolonged release) 90 mg in single dose pre-filled applicator

4
The treatment must be for luteal phase support
 
Progesterone
Vaginal tablet  100 mg

5
The treatment must be for luteal phase support
 
Progesterone
Pessary 100 mg
 

6
The treatment must be for luteal phase support
 
Progesterone
Pessary 200 mg